“ Crystalline glucosamine sulfate … NSAID consumption by up to 36% (OR = 0.64; 95% CI: 0.45-0.92) in the primary analysis foreseen by the protocol; OR …. at the very limit of significance, in a sensitivity analysis accounting for an extension of the study and of the control cohort.”